http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3067453-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a69681008a628a443257b49621b2e506 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate | 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5afdea3e7bd5b0987f2e21c88b078cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd2ca7a43c09e21560b4c080748fe907 |
publicationDate | 2018-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-3067453-A1 |
titleOfInvention | Agent for preventing or treating brain atrophy |
abstract | The present invention addresses the problem of providing a chemical agent for suppressing the progression of Alzheimer-type dementia and a method for suppressing the progression of Alzheimer-type dementia. 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof has an effect of suppressing brain atrophy, and is useful as a prophylactic or therapeutic agent for brain atrophy. Thus, it is possible to prevent or treat brain atrophy observed in the aging process or in neurodegenerative diseases by administering 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof. |
priorityDate | 2017-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.